Evidence map›Paper›PMID 29597356›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2018

Complement Factor D protects mice from ethanol-induced inflammation and liver injury.

Rebecca L McCullough, Megan R McMullen, Megan M Sheehan, Kyle L Poulsen, Sanjoy Roychowdhury, Dian J Chiang, Michele T Pritchard, Juan Caballeria, Laura E Nagy

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver Disease.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Role of Complement in Liver Diseases.Seminars in liver disease · 2024
    Review
  11. Review
  12. NLRP3 Inflammasome in Acute and Chronic Liver Diseases.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rebecca L McCulloughDepartment of Pathobiology, Center for Liver Disease Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio.
Megan R McMullenDepartment of Pathobiology, Center for Liver Disease Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio.
Megan M SheehanDepartment of Pathobiology, Center for Liver Disease Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio.
Kyle L PoulsenDepartment of Pathobiology, Center for Liver Disease Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio.
Sanjoy RoychowdhuryDepartment of Pathobiology, Center for Liver Disease Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio.
Dian J ChiangDivision of Gastroenterology, Swedish Medical Group , Seattle, Washington.
Michele T PritchardDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center , Kansas City, Kansas.ORCID 0000-0002-0095-0685
Juan CaballeriaInstitut d'Investigacions Biomediques August Pi iSunyer, Hospital Clinic of Barcelona , Barcelona , Spain.
Laura E NagyDepartment of Pathobiology, Center for Liver Disease Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio.
Cleveland Clinic Lerner College of Medicine · USCleveland Clinic · USHospital Clínic de Barcelona · ESSwedish Medical Center · USUniversity of Kansas Medical Center · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Project Two - Exercise Training Decreases Alcohol Drinking by an FGF21-Dependent MechanismP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Thomas M McIntyre · 2016 to 2026
$19.6M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI AMITABH CHAK · 2015 to 2026
$15.6M
TRAINING IN METABOLISMT32DK007319 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUNENGRABER, HENRI · 1986 to 2013
$5.0M
Role of Adipose in Ethanol-Induced Tissue InjuryR37AA011876 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2009 to 2018
$4.0M
MIF in progression and treatment of ALDU01AA020821 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2012 to 2016
$2.1M
Inflammaging and ADRD: Investigating the Role of Complement and Alcohol.R00AA025386 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI SMATHERS MCCULLOUGH, REBECCA LEANNE · 2018 to 2020
$993k
Spinning Disk Confocoal MicroscopeS10RR026820 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2010 to 2010
$500k
Altered Treg differentiation in ALD: a novel role for anaphylatoxins C3a and C5aK99AA025386 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI SMATHERS MCCULLOUGH, REBECCA LEANNE · 2017 to 2018
$222k
NCATS NIH HHS UL1 TR002548NCRR NIH HHS S10 RR026820NCRR NIH HHS UL1 RR024989NIAAA NIH HHS K99 AA025386NIAAA NIH HHS P50 AA024333NIAAA NIH HHS R00 AA025386NIAAA NIH HHS R37 AA011876NIAAA NIH HHS U01 AA020821NIDDK NIH HHS P30 DK097948NIDDK NIH HHS T32 DK007319
6 · The paper itself

Abstract

Complement plays a crucial role in microbial defense and clearance of apoptotic cells. Emerging evidence suggests complement is an important contributor to alcoholic liver disease. While complement component 1, Q subcomponent (C1q)-dependent complement activation contributes to ethanol-induced liver injury, the role of the alternative pathway in ethanol-induced injury is unknown. Activation of complement via the classical and alternative pathways was detected in alcoholic hepatitis patients. Female C57BL/6J [wild type (WT)], C1q-deficient ( C1qa

Indexed as

EthanolInflammationAnimalsApoptosisCentral Nervous System DepressantsComplement Factor DComplement Pathway, AlternativeCytokinesLiverLiver Diseases, AlcoholicMiceMice, Inbred C57BLProtective AgentsCentral Nervous System DepressantsComplement Factor Dcomplement factor D, mouseCytokinesEthanolProtective Agentsalcoholic liver diseaseapoptosissteatosis

Identifiers

PMID29597356
PMCPMC6109707
OpenAlexW2794875758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.